Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Genetown crawled date : 2021 - 09 - 09 save search
VOR33 Granted U.S. FDA Fast Track Designation for AML
Published: 2021-09-09 (Crawled : 14:00) - biospace.com/
VOR | $1.685 -2.6% -2.67% 150K
|
|
| O: 3.85%
H: 3.03%
C: -3.21%
fda fda fast track fast track granted fast track designation grant designation aml
Allena Pharmaceuticals to Participate in H.C. Wainwright’s 23rd Annual Global Investment Conference
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
ALNA | $0.075 -12.0%
|
Health Technology
|
| O: 0.0%
H: 2.91%
C: 1.94%
conference
Aldeyra Therapeutics to Participate in the Virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
ALDX 4 | $3.99 0.5% 0.5% 430K
|
Health Technology
|
| O: -0.11%
H: 0.9%
C: 0.0%
life science
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
WVE | $4.8 0.21% 0.21% 540K
|
Health Technology
|
| O: 0.34%
H: 4.48%
C: 2.7%
huntington disease phase 1 life science trial phase 1b phase 2b huntington’s disease
Xenetic Biosciences, Inc. Receives Notice of Allowance for XCART(TM) Patent
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
XBIO | $4.165 7.9% 7.32% 7.9K
|
Health Technology
|
| O: -1.14%
H: 3.85%
C: 1.15%
patent bioscience
Syros Announces First Patient Dosed in SELECT-AML-1 Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Newly Diagnosed Unfit AML
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
SYRS | $4.76 -6.85% -7.35% 120K
|
Health Technology
|
| O: -0.76%
H: 4.23%
C: 1.54%
trial aml
Rapid Micro Biosystems Set to Join Russell 2000®, Russell 3000® and Russell Microcap® Indexes
Published: 2021-09-09 (Crawled : 12:00) - biospace.com/
RPID | $0.8605 -8.46% -9.24% 140K
|
|
| O: 0.94%
H: 8.05%
C: 1.61%
set
KalVista Pharmaceuticals Reports First Fiscal Quarter 2021 Results
Published: 2021-09-09 (Crawled : 11:00) - biospace.com/
KALV | $11.53 -1.03% -1.04% 410K
|
Health Technology
|
| O: -1.23%
H: 8.12%
C: 5.18%
results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.